title: Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with risperidone.
authors.forename: C
authors.initials: C
authors.lastname: van der Linden
authors.forename: R
authors.initials: R
authors.lastname: Bruggeman
authors.forename: T C
authors.initials: TC
authors.lastname: van Woerkom
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D018492:Dopamine Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination / Q000187:drug effects; D010865:Pilot Projects; D010880:Piperidines / Q000008:administration & dosage* / Q000009:adverse effects; D018967:Risperidone; D012702:Serotonin Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D005879:Tourette Syndrome / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D007555:Isoxazoles; D010880:Piperidines; D012702:Serotonin Antagonists; D018967:Risperidone